Your browser doesn't support javascript.
loading
Mathematical modeling and simulation in animal health - Part II: principles, methods, applications, and value of physiologically based pharmacokinetic modeling in veterinary medicine and food safety assessment.
Lin, Z; Gehring, R; Mochel, J P; Lavé, T; Riviere, J E.
Afiliação
  • Lin Z; Institute of Computational Comparative Medicine (ICCM), Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA.
  • Gehring R; Institute of Computational Comparative Medicine (ICCM), Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA.
  • Mochel JP; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, Basel, Switzerland.
  • Lavé T; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, Basel, Switzerland.
  • Riviere JE; Institute of Computational Comparative Medicine (ICCM), Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA.
J Vet Pharmacol Ther ; 39(5): 421-38, 2016 Oct.
Article em En | MEDLINE | ID: mdl-27086878
ABSTRACT
This review provides a tutorial for individuals interested in quantitative veterinary pharmacology and toxicology and offers a basis for establishing guidelines for physiologically based pharmacokinetic (PBPK) model development and application in veterinary medicine. This is important as the application of PBPK modeling in veterinary medicine has evolved over the past two decades. PBPK models can be used to predict drug tissue residues and withdrawal times in food-producing animals, to estimate chemical concentrations at the site of action and target organ toxicity to aid risk assessment of environmental contaminants and/or drugs in both domestic animals and wildlife, as well as to help design therapeutic regimens for veterinary drugs. This review provides a comprehensive summary of PBPK modeling principles, model development methodology, and the current applications in veterinary medicine, with a focus on predictions of drug tissue residues and withdrawal times in food-producing animals. The advantages and disadvantages of PBPK modeling compared to other pharmacokinetic modeling approaches (i.e., classical compartmental/noncompartmental modeling, nonlinear mixed-effects modeling, and interspecies allometric scaling) are further presented. The review finally discusses contemporary challenges and our perspectives on model documentation, evaluation criteria, quality improvement, and offers solutions to increase model acceptance and applications in veterinary pharmacology and toxicology.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicina Veterinária / Farmacocinética / Modelos Estatísticos / Inocuidade dos Alimentos Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicina Veterinária / Farmacocinética / Modelos Estatísticos / Inocuidade dos Alimentos Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2016 Tipo de documento: Article